Table 4.
Inpatient Physical Therapy Treatment | Lumbar Epidural Steroid Injections | Control Group |
---|---|---|
• Ultrasound for 10 minutes | • Used intralaminar method | No treatment |
• 20 minutes of hot pack | • 3 mL of contrast followed by 10 mL of combination of triamcinolone (60 mg), 0.5% bupivacaine hydrochloride (15 mg), and normal saline (5.5 mL) | |
• 20 minutes of TENS to lumbar region of back | ||
• Conservative program given 5 days per week for 2 weeks | ||
| ||
Nottingham Health Profile; Changes in Median Scores | Nottingham Health Profile; Changes in Median Scores | Nottingham Health Profile; Changes in Median Scores |
| ||
Pain (VAS) | Pain (VAS) | Pain (VAS) |
Baseline: 54.1 | Baseline: 56.3 | Baseline: 58.6 |
2-week follow-up: 19.4 | 2-week follow-up: 7.3 | 2-week follow-up: 33.0 |
1-month follow-up: 31.2 | 1-month follow-up: 36.2 | 1-month follow-up: 20.1 |
3-month follow-up: 18.2 | 3-month follow-up: 20.5 | 3-month follow-up: 27.7 |
6-month follow-up: 23.2 | 6-month follow-up: 23.0 | 6-month follow-up: 20.1 |
Physical mobility | Physical mobility | Physical mobility |
Baseline: 41.8 | Baseline: 41.8 | Baseline: 41.8 |
2-week follow-up: 31.2 | 2-week follow-up: 21.9 | 2-week follow-up: 31.2 |
1-month follow-up: 37.2 | 1-month follow-up: 31.9 | 1-month follow-up: 20.5 |
3-month follow-up: 32.5 | 3-month follow-up: 31.2 | 3-month follow-up: 31.0 |
6-month follow-up: 37.1 | 6-month follow-up: 31.2 | 6-month follow-up: 20.5 |
Energy | Energy | Energy |
Baseline: 88.0 | Baseline: 100 | Baseline: 63.2 |
2-week follow-up: 30.4 | 2-week follow-up: 60.8 | 2-week follow-up: 63.2 |
1-month follow-up: 24.0 | 1-month follow-up: 100 | 1-month follow-up: 60.8 |
3-month follow-up: 30.4 | 3-month follow-up: 62.0 | 3-month follow-up: 100 |
6-month follow-up: 48.8 | 6-month follow-up: 81.6 | 6-month follow-up: 63.2 |
Sleep | Sleep | Sleep |
Baseline: 55.9 | Baseline: 58.0 | Baseline: 55.9 |
2-week follow-up: 31.8 | 2-week follow-up: 26.2 | 2-week follow-up: 12.5 |
1-month follow-up: 12.5 | 1-month follow-up: 44.7 | 1-month follow-up: 12.5 |
3-month follow-up: 12.5 | 3-month follow-up: 14.3 | 3-month follow-up: 28.6 |
6-month follow-up: 12.5 | 6-month follow-up: 25.5 | 6-month follow-up: 28.6 |
Social isolation | Social isolation | Social isolation |
Baseline: 28.9 | Baseline: 41.7 | Baseline: 0.0 |
2-week follow-up: 18.0 | 2-week follow-up: 22.0 | 2-week follow-up: 0.0 |
1-month follow-up: 18.9 | 1-month follow-up: 22.0 | 1-month follow-up: 0.0 |
3-month follow-up: 11.0 | 3-month follow-up: 32.0 | 3-month follow-up: 0.0 |
6-month follow-up: 0.0 | 6-month follow-up: 32.3 | 6-month follow-up: 0.0 |
Emotional reactions | Emotional reactions | Emotional reactions |
Baseline: 33.0 | Baseline: 45.0 | Baseline: 23.7 |
2-week follow-up: 17.1 | 2-week follow-up: 13.3 | 2-week follow-up: 0.0 |
1-month follow-up: 15.1 | 1-month follow-up: 46.1 | 1-month follow-up: 9.7 |
3-month follow-up: 0.0 | 3-month follow-up: 41.4 | 3-month follow-up: 9.7 |
6-month follow-up: 6.9 | 6-month follow-up: 27.5 | 6-month follow-up: 0.0 |
Abbreviations: TENS, transcutaneous electrical nerve stimulation; VAS, Visual Analog Score.